You are here

PANCREATOBILIARY VERSUS INTESTINAL TYPE OF HISTOLOGICAL DIFFERENTIATION: A COMPARATIVE STUDY WITH HISTOMORPHOLOGICAL PROGNOSTIC FACTORS IN PERIAMPULLARY CARCINOMA

Journal Name:

Publication Year:

DOI: 
10.5958/j.2319-5886.2.3.067
Abstract (2. Language): 
Objectives: Periampullary carcinoma is a term widely used to define a heterogenous group of neoplasms arising from the head of the pancreas, ampulla of Vater, terminal common bile duct and the duodenum. Periampullary carcinomas typically have either the intestinal type or pancreatobiliary type of the differentiation. The prognostic importance of the type of differentiation is studied in relation to the other prognostic factors like resection margin involvement, tumour size, nodal involvement, vascular infiltration, perineural growth and degree of differentiation. Methods: 50 whipples resected specimens were analyzed. In these cases 33 were periampullary carcinomas and the remaining were chronic pancreatitis. The clinical features, laboratory investigations and histopathological features of periampullary carcinomas were studied. Prognostic factors were studied in two histological types of periampullary carcinomas i.e. intestinal type and pancreatobiliary type. Results: Out of 33 periampullary carcinomas 24 were intestinal type and 9 were pancreatobiliary type. Periampullary carcinomas were common in females (54.5%) and were seen mostly in the age above 60yrs (36.4%). Jaundice was the most common presenting symptom. Independent adverse prognostic factors seen in the pancreatobiliary type of differentiation were tumor size more than 2.5cm (66.7%), tumor stage, regional lymphnode involvement (77.8 %), vessel involvement (55.6%), perineural growth, areas with poor differentiation (66.7%) and serum CA19-9 levels more than 200U/ml (77.8%). Conclusion: In periampullary carcinomas histological type of differentiation is very important independent prognostic factor. In the two histological types of carcinomas pancreatobiliary has worse prognosis when compared to intestinal type.
FULL TEXT (PDF): 
380-387

REFERENCES

References: 

1. Sang Myung Woo, Jiken Ryu, Sang Hyub
Lee, Ji Won Yoo et al. recurrence and
prognostic factors of ampullary carcinoma
after radical resection: comparision with
distal extrahepatic cholangiocarcinoma.
Annals of Surgical Oncology 2007;14(11):
3195-01.
2. Albores SJ, Henson DE, Klimstra DS.
Malignant epithelial tumors of ampulla. In:
Tumors of gall bladder, extrahepatic
bileducts and ampulla of vater. Washington
DC: Armed Forces Institute of Pathology
2000;259-316.
3. De Qing Mu, You-Shu Peng, Feng-Guo
Wang, Qiao-Jian Xu. Significance of
perigastric lymphnode involvement in
Periampullary malignant tumor. World J
Gastroenterol 2004; 10(4):614-16.
4. Ries LAG, Miller BA, Hankey BF, Kosary
CL, Harras A, Edwaeds BK, Editor SEER
Cancer stastics review,1973-1991:Tables and
graphs Bethesda (MD): National Cancer
Institute: 1994; 94:2789.
5. Carlos Chan, Miguel F. Herrera, Lorenzode
La Garza, Leticia Quintanilla-Martinez,
Florenciavargas-Vorackova et al. Clinical
behavior and prognostic factors of
386
Vissa Shanthi et al., Int J Med Res Health Sci. 2013;2(3):380-387
periampullary adenocarcinoma. Annals of
Surg 1995; 222(5):632-37.
6. Taxiarchis Botsis, Valsamo KA, Gunnar
Hartvigsen, Georges Hripisak and
Chunhuaweng. Modeling prognostic factors
in resectable pancreatic adenocarcinoma.
Cancer inform 2009;7:281-91.
7. Elkharwily A, Gottlieb K. The pancreas in
familial adenomatous polyposis. JOP
2008;9(1):9-18.
8. Lowenfels AB, Maisonneuve P. Pancreatic
cancer: Development of unifying etiologic
concept. Ann Ny Acad Sci 1999;88:191-200.
9. Hustinx SR, Hruban RH, Leini LM,
Lacobuzio-donahuec, Cameron TL, Yeo CJ.
Homozygous deletion of the MJAP gene in
invasive adenocarcinoma of the pancreatic
and in periampullary cancer; a potential new
target for therapy. Cancer Biol Ther Jn
2005;4(1):83-6.
10. Hower GR, Burch JD. Nutrition and
pancreatic cancer. Cancer causes control
1996;7:69-82.
11. Howtson AG, Carter DC. Pancreatic
carcinogenesis effect of secretion in the
hamster-nitrosamine model. J Natl Cancer
Inst 1987;78:101-5.
12. Talamini MA, Moesinger RC, Pitt HA, Sohn
TA, Hruban RH, Lillemoe KD.
Adenocarcinoma of the ampulla of vater. A
28-year experience. Ann Surg
1997;225(5):590-9.
13. Westgaard A, Tafjord S, Farstad IN,
Cvancarova M, Eide TJ, Mathisen O,
Clausen OP, Gladhaung IP. Pancreatobiliary
versus intestinal histologic type of
differentiation is an independent prognostic
factor in resected periampullary
adenocarcinoma. BMC Cancer 2008;8:170.
14. Kimura W, Futukawa N, Yamagata S, Wada
Y, Kuroda A, Muto T, Esali Y. Different
clinicopathologic findings in two
histopathologic types of carcinomas of
ampulla of vater. Jpn J Cancer Reg 1994;
85(2):161-6.
15. Boce VM, Gamagami GA, Gilpin EA.
Factors influencing survival after resection
for periampullary neoplasm. Am J Surg
2000;180:13-17.
16. Bockma DE, Buchler M, Beger HG.
Interaction of pancreatic ductal carcinoma
with nerves leads to nerve damage.
Gastroenterology 1994;107:219-230.
17. Ferrone CR, Finkelstein DM, Thayer SP et
al. Preoperative CA 19-9 levels or predict
stage and survival in patients with resectable
pancreatic adenocarcinoma. J Clin Oncol
2006;24:2897-902.

Thank you for copying data from http://www.arastirmax.com